INTERNATIONAL SYMPOSIUM

TRAILBLAZING IN CANCER IMMUNOTHERAPY.

October 29th – 31st 2017

Pamplona, Navarra, Spain

Immunotherapy strategies against cancer are emerging as powerful weapons for treatment of this disease. The success of checkpoint inhibitors against metastatic melanoma and adoptive T-cell therapy with chimeric antigen receptor T cells against B-cell-derived leukemias and lymphomas are only two examples of developments that are changing the paradigms of clinical cancer management.

EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Add to My Calendar 2017-10-29 16:00:00 2017-10-31 18:00:00 Europe/Madrid International Symposium: Trailblazing in cancer Immunotherapy Pamplona, Spain Centro para la Investigación Médica Aplicada - CIMA cththemes@gmail.com

SYMPOSIUM COORDINATORS

Dr. Ignacio Melero

Dr. Pedro Berraondo

Dr. Jose Luis Pérez Gracia

FULL PROGRAM

Registration and congress documentation

15:45

Opening

Mariano Barbacid (Fundación Areces), Jesús San Miguel, Ignacio Melero, Jose Luis Pérez Gracia, Pedro Berraondo

16:15

Keynote Lecture

Chair: Pedro Berraondo. CIMA. Ignacio Melero. CIMA y CUN

Future of cancer immunotherapy: Enhancement or normalization?

Lieping Chen. Yale. USA

16:30

Break

17:00

Exploiting tumor antigenicity

Chair: Juanjo Lasarte. CIMA. Pablo Sarobe. CIMA

The Yin and Yang of Cancer Immunotherapy Combinations. 18.00.

Daniel Chen. Roche Genentech. USA

Targeting Ideal Antigens for Cancer Immunotherapy. 18.40.

Özlem Türeci. BioNTech. Germany

Cancer immunotherapy beyond PD-1: novel pathways and combinations. 19.20.

Andrea van Elsas. ADURO. Netherlands

Radiotherapy and immunotherapy shoulder to shoulder into the fray. 20.00.

Silvia Formenti. Cornell. USA

18:00

Immunotherapy development: industrial view and pipelines (1)

Chair: Jose Luis Pérez Gracia. CUN, Felipe Calvo.Hospital Gregorio Marañon. Madrid

Novel Drug Combinations for Cancer Immunotherapy. 09.00.

Nils Lonberg. BMS. USA

Medimmune cancer immunotherapy approach. 09.20.

Bahija Jallal. Medimmune. USA

MSD cancer immunotherapy approach. 09.40.

David Kaufman. MSD.

09:00

Round table discussion

10:00

Coffee break

10:40

Immunotherapy development: industrial view and pipelines (2)

Chair: Luis Paz-Ares. Hospital Universitario Doce de Octubre. Madrid. Spain, Luis Montuenga. CIMA

11.00. Advances in CAR T cell therapy: CD19 Therapy and Beyond

Jennifer Brogdon. Novartis. USA

11.20. Building a Next-Generation Immuno-Oncology Pipeline in a Competitive Space: Perspectives from a “New Kid on the Block”

Lazslo Radvanyi. Merck Serono. USA

11.40. A therapeutic strategy to target cold tumors

Eric Borges. Boehringer Ingelheim. Germany

12.00. The Lilly Immunooncology pipeline: enabling rational combinations

Michael Kalos. Lilly. USA

11:00

Round table discussion

12:20

Lunch break

12:45

Keynote lecture

Chair: Ignacio Melero. CIMA y CUN, Ruth Vera. Hospital de Navarra.

Clinical development of lung cancer immunotherapy

Luis Paz-Ares. Hospital Universitario Doce de Octubre. Madrid. Spain

14:00

Immunotherapy based on evidence

Chair: Ruben Pío. CIMA, María Rodríguez. CIMA y CUN

14.30. Targeting immune modulation at the tumour site.

Sergio Quezada. UCL. UK

15.10. Anti-cancer immune therapy of melanoma

Mario Sznol. Yale. USA

15.50. Exploiting radiotherapy in immunotherapy combinations

Timothy Illidge. The University of Manchester. UK

14:30

Immunotherapy biomarkers working in the tissue

Chair: Dolores Lozano. CUN, Michel Idoate. CUN

16.30. Understanding the tumor immune composition using multiplexed
quantitative approaches

Kurt Schalper. Yale. USA

17.10. Diagnostics in the era of Cancer Immunotherapy

Priti Hegde. Roche Genentech. USA

17.50. Role of Immunotherapy in Hodgkin and non-Hodgkin Lymphomas

Scott J. Rodig. Brigham and Women’s Hospital. USA

16:30

TNFR costimulation in action

Chair: David Escors. Navarrabiomed. Spain, Fernando Pastor. CIMA

CD40 stimulation: the rules of a complex game. 09.00.

Ann White. UCB Celltech. UK

Moving forward CD137-based immunotherapies. 09.40.

Ignacio Melero. CIMA y CUN

GITR and 4-1BB in chronic viral infection: implications for cancer therapy. 10.20.

Tania Watts. University of Toronto. Canada

09:00

Coffee break

11:00

Genetics and genetic intervention for better immunotherapies

Chair: Cristian Smerdou. CIMA, Ruben Hernández Alcoceba. CIMA

Identification of immunoreactive microsatellite stable (MSS) colorectal cancer for potential immune interventions. 11.30.

Nicolas J LLosa. Johns Hopkins. USA

Deconstructing the T cell Receptor signaling nanomachine. 12.10.

Balbino Alarcón. CBM. Spain

Viruses and IFNα/ß in immunotherapy. 12.50.

Pedro Berraondo. CIMA

Viral gene therapies. 13.30.

Ramón Alemany. VCN. Spain

11:30

Lunch break

14:10

Exploiting new tools to improve immunotherapy

Chair: Susana Inogés. CUN, Ignacio Gil Bazo. CUN

Complement in cancer immunotherapy. 15.30.

Rubén Pío. CIMA. Spain

Patient-derived tumor models for immunotherapy development. 16.10.

Miguel Sanmamed. Yale. USA

Identifying T cells specific against cancer. 17.00.

Alena Gros. Vall d´Hebron. Spain 

15:30

Where to stay

Finding a good hotel can be tricky. So here are some of our favorite hotels nearby event location

Abba Reino de Navarra ****s

From 75€ per night

Visit Website

Albret ****

From 74€ per night

Visit Website

Blanca de Navarra ****

From 85€ per night

Visit Website

Sancho Ramirez ***

From 85€ per night

Visit Website

REGISTRATION

Inscription
80 €
  • Access to all events (free)
  • Coffee / Lunch
  • Documentation
  • Certification

REGISTRATION

Frequently Asked Questions
How can I get to the venue?

The map and Contact details are listed within the contact information.You will also receive a confirmation email with location map.

What about accommodation?

The cost of the hotel accommodation and travel expenses are not included in the event fee.

What payment types do you accept?

All payments are to be made with VISA or MASTERCARD and they are processed via Redsys.

Can I get a refund on my tickets?

All tickets have their own conditions and in each case you will have the information before the emission.

EVENT SUPPORTED BY

WITH THE COLLABORATION

GET DIRECTIONS

Fill the form below to get directions to our event location

Enter Direction from and Travel Mode from the left form to see directions.

ADDRESS

Museo Universidad de Navarra

Campus Universitario, s/n

31009 Pamplona, Navarra

Navarra, Spain

CONTACT

FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (FIMA)

Contact person: Cibeles Pinto

simposioareces@unav.es

+34 948 19 47 00  Ext. 4012

SECRETARY

Viajes Arga
Contact person: Mr. Jaime Zaragueta
Monasterio de Tulebras, 2
31011 Pamplona, Navarra, Spain

jaime@viajesarga.com

+34 948 19 92 22

SEND US A MESSAGE

If you have any questions about the event, please contact us directly. We will respond immediately.






LETS GATHER TOGETHER

JOIN THE CONFERENCE

back to top